Suppr超能文献

类风湿关节炎高凝状态患者的综合回顾及降低再入院率的策略:一项基于中医保护性探索的回顾性队列研究

Comprehensive review of patients with hypercoagulable state in rheumatoid arthritis and strategies to reduce readmission rates: A retrospective cohort study based on protective exploration of traditional Chinese medicine.

作者信息

Li Yang, Liu Jian, Hu Yuedi, Cong Chengzhi, Chen Yiming, Wang Fanfan

机构信息

Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

First Clinical Medical School, Anhui University of Chinese Medicine, Hefei, China.

出版信息

Medicine (Baltimore). 2024 Dec 13;103(50):e40890. doi: 10.1097/MD.0000000000040890.

Abstract

This study aimed to investigate the effect of traditional Chinese medicine (TCM) intervention on the risk of readmission and laboratory indicators in patients with rheumatoid arthritis hypercoagulable state. In the retrospective cohort design, patients with RA hospitalized between June 2013 and June 2021 at the First Affiliated Hospital of Anhui University of Chinese Medicine were followed up by telephone. Propensity score matching (PSM) was used to balance deviations in baseline information between patients in the hypercoagulable (HC) and non-hypercoagulable (Non-HC) groups, with exposure defined as receiving TCM treatment for ≥ 1 month. Cox proportional hazards model and Kaplan-Meier survival curves were employed to determine the factors influencing the readmission of RA-HC patients. Mantel test and association rule analysis was used to explore the relationship between the included factors and laboratory indicators. A total of 1169 cases were successfully followed up, including 831 RA-HC patients. 1:2 PSM yielded 311 patients in the non-HC group versus 535 patients in the HC group. We observed that the incidence of readmission and surgical treatment was significantly higher in the HC group than in the non-HC group, while the incidence of readmission, surgical treatment, and all-cause mortality was much lower in the exposed group than in the non-exposed group (all P < .05). Based on the Cox proportional risk model, we identified age above 60 years, Sjogren's syndrome, neutrophil count, and neutrophil-lymphocyte ratio (NLR) as risk factors for readmission, with TCM playing a protective role. The Kaplan-Meier survival curves further showed that the risk of readmission in the high-exposure subgroup was markedly lower than that of the low-exposure subgroup. Furthermore, the Mantel test highlights an intrinsic correlation between coagulation markers and other markers such as erythrocyte sedimentation rate (ESR) and hypersensitive c-reactive protein (hs-CRP), which are dramatically influenced by gender, age, etc. In addition, association rule analysis revealed a strong correlation between TCM and non-readmission, as well as improvement in rheumatoid factor, hs-CRP, ESR, platelet count, and NLR in RA-HC patients. As a promising therapeutic strategy, TCM with sufficient intensity and duration interventions can effectively reduce the risk of readmission and relieve laboratory indicators in RA-HC patients.

摘要

本研究旨在探讨中医干预对类风湿关节炎高凝状态患者再入院风险及实验室指标的影响。采用回顾性队列设计,对2013年6月至2021年6月期间在安徽中医药大学第一附属医院住院的类风湿关节炎患者进行电话随访。采用倾向评分匹配(PSM)方法平衡高凝(HC)组和非高凝(Non-HC)组患者基线信息的偏差,将接受≥1个月中医治疗定义为暴露。采用Cox比例风险模型和Kaplan-Meier生存曲线确定影响类风湿关节炎高凝患者再入院的因素。采用Mantel检验和关联规则分析探讨纳入因素与实验室指标之间的关系。共成功随访1169例患者,其中类风湿关节炎高凝患者831例。1:2的PSM产生了311例非HC组患者和535例HC组患者。我们观察到,HC组的再入院率和手术治疗发生率显著高于非HC组,而暴露组的再入院率、手术治疗发生率和全因死亡率远低于非暴露组(所有P<0.05)。基于Cox比例风险模型,我们确定年龄大于60岁、干燥综合征、中性粒细胞计数和中性粒细胞与淋巴细胞比值(NLR)为再入院的危险因素,中医起到保护作用。Kaplan-Meier生存曲线进一步显示,高暴露亚组的再入院风险明显低于低暴露亚组。此外,Mantel检验突出了凝血标志物与其他标志物如红细胞沉降率(ESR)和超敏C反应蛋白(hs-CRP)之间的内在相关性,这些标志物受性别、年龄等因素影响显著。此外,关联规则分析显示中医与非再入院以及类风湿关节炎高凝患者类风湿因子、hs-CRP、ESR、血小板计数和NLR的改善之间存在强相关性。作为一种有前景的治疗策略,具有足够强度和持续时间干预的中医可有效降低类风湿关节炎高凝患者的再入院风险并缓解实验室指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1410/11651460/e2f0ddd0b07b/medi-103-e40890-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验